Shane Ward - 31 Mar 2025 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
COO & CLO
Signature
/s/ Shane Ward
Issuer symbol
CDTX
Transactions as of
31 Mar 2025
Net transactions value
$0
Form type
4
Filing time
02 Apr 2025, 18:27:34 UTC
Previous filing
13 Mar 2025
Next filing
12 Dec 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Award $0 +25,000 +170% $0.000000 39,674 31 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDTX Employee Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 31 Mar 2025 Common Stock 50,000 $21.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based Restricted Stock Units (RSUs) granted on March 31, 2025. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2026, 2027, and 2028, subject to continuous service through each such vesting date.
F2 The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2025.